Rhonda Farnum - Nov 20, 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Nov 20, 2023
Transactions value $
-$96,953
Form type
4
Date filed
11/22/2023, 06:07 PM
Previous filing
Aug 24, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$82.8K -7.98K -2.34% $10.37 333K Nov 20, 2023 Direct F1
transaction TBPH Ordinary Shares Sale -$14.2K -1.38K -0.41% $10.29 331K Nov 21, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
F2 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023.